* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Christopher Vinnard - Public Health Research Institute
Survey
Document related concepts
Race and health wikipedia , lookup
Eradication of infectious diseases wikipedia , lookup
Focal infection theory wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Epidemiology wikipedia , lookup
Diseases of poverty wikipedia , lookup
Transmission (medicine) wikipedia , lookup
Compartmental models in epidemiology wikipedia , lookup
Public health genomics wikipedia , lookup
Index of HIV/AIDS-related articles wikipedia , lookup
Transcript
Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] Office Address: Public Health Research Institute New Jersey Medical School Rutgers, The State University of New Jersey 225 Warren Street Newark, NJ 07103 Education: 05/1995 05/2002 05/2002 05/2010 B.A. (magna cum laude) M.D. M.P.H. M.S.C.E. Amherst College (Physics) Tulane University School of Medicine Tulane School of Public Health and Tropical Medicine Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Postgraduate Training and Fellowship Appointments: 07/2002-06/2003 Intern in Medicine, New York University, New York City 07/2003-06/2005 Resident in Medicine, New York University, New York City 07/2007-06/2011 Fellowship, Infectious Diseases, Hospital of the University of Pennsylvania, Philadelphia Hospital and Administrative Appointments: 7/2005-8/2005 Attending Physician, Indian Health Service, Pine Ridge, South Dakota 8/2005-10/2005 Attending Physician, Ketchikan General Hospital, Ketchikan, Alaska 11/2005-12/2005 Attending Physician, Walker Baptist Memorial Hospital, Jasper, Alabama 5/2006-6/2007 Attending Physician, Gouverneur Healthcare Services, New York, NY 7/2009- 6/2011 Attending Physician, Philadelphia VAMC, Philadelphia, PA 7/2011- 2/2016 Assistant Professor, Drexel University College of Medicine, Philadelphia, PA 2/2016- present Assistant Professor, New Jersey Medical School, Newark, NJ Other Activities 1/2006-4/2006 Foreign language study and travel, Liaocheng University, China Other Appointments: 1995-1996 Lecturer in Mathematics, Temasek Polytechnic, Singapore 1997-1998 Instructor of English as a Second Language, Venezuela Specialty Certification: 2005 Diplomate, American Board of Internal Medicine 2007 Certificate of Knowledge in Clinical Tropical Medicine and Travelers’ Health, American Society of Tropical Medicine and Hygiene 2009 Diplomate in Infectious Diseases, American Board of Internal Medicine Active Licensure: Pennsylvania (No. 431922) Memberships in Professional & Scientific Societies: 2011-present Member, American Medical Association Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] 2014-present Member, Infectious Disease Society of America Awards, Honors, and Membership in Honorary Societies: 2009 Robert Austrian Award for Outstanding Fellow, Division of Infectious Diseases, University of Pennsylvania School of Medicine 2009 NIH Loan Repayment Program Award 2010 Scholarship Award, 26th International Conference on Pharmacoepidemiology 2010 Infectious Disease Fellows Grant, 50th Interscience Conference of Antimicrobial Agents and Chemotherapy 2010 Fellows Travel Grant, 48th Annual Meeting of the Infectious Disease Society of America 2010 Special Citation for Fellows-in-Training, 48th Annual Meeting of the Infectious Disease Society of America 2011 NIH Loan Repayment Program Award (competitive renewal) 2012 Citation for “among the best reviews of 2011”, Pharmacoepidemiology and Drug Safety 2013 NIH Loan Repayment Program Award (competitive renewal) 2015 Excellence in Teaching Award, Department of Family Medicine, Drexel University College of Medicine Educational Activities: 2006-2007 Doctoring course for medical students, New York University School of Medicine 2008-2011 Infectious disease elective for medical students, University of Pennsylvania School of Medicine 2011-2016 Core curriculum courses, Infectious Disease Fellowship, Drexel University College of Medicine 2011-2016 Lecturer, HIV Medical Management Course, Drexel University College of Medicine 2012-2016 Resident Lecture Series, Principles of Biomedical Research, “Biomedical Research Ethics: Case Studies and Quandries” 2012-2016 Lecturer, Internal Medicine Board Review, Skin and Soft Tissue Infections, Drexel University College of Medicine 2015-2016 Lecturer, Internal Medicine Board Review, Invasive Fungal Infections, Drexel University College of Medicine Editorial Activities: 2009-present Peer Reviewer: 1. Emerging Infectious Diseases 2. Journal of Infection 3. BMC Public Health 4. Clinical Infectious Diseases 5. BMC Infectious Disease 6. Pharmacoepidemiology and Drug Safety 7. Transplant Infectious Diseases 8. Clinical and Developmental Immunology Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] 9. Epidemiology and Infection 10. Infectious Disease Reports 11. Nicotine & Tobacco Research 12. Infectious Diseases 13. Transplant International 14. American Journal of Respiratory and Critical Care Medicine 15. Annals of the American Thoracic Society 16. Public Health Reports Other Service Related to Professional Work: 2012-2015 External Reviewer of AIDS-defining events, AIDS Clinical Trials Group (ACTG) study A5274 2014 Peer reviewer, Medical Research Council, UK 2014-2016 Member, Tuberculosis Transformative Science Group, ACTG 2015 Peer reviewer, British Society for Antimicrobial Chemotherapy Grants Program, UK 2016 Review panel member, Brody Family Medical Trust Fund, College of Physicians of Philadelphia Invited Lectures: October 2009 Tuberculous Meningitis in the United States 1993-2005: Risk factors for initial Isoniazid resistance, and the association of initial isoniazid resistance with mortality. Centers for Disease Control, Division of Tuberculosis Elimination, Surveillance and Epidemiology Branch, Atlanta, GA November 2010 Drug Resistant Tuberculous Meningitis: How clinical pharmacology can provide the framework for an epidemiologic investigation. Society for Clinical and Biomedical Research, Philadelphia, PA March 2011 Risk Factors for Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients. Penn Center for Education and Research on Therapeutics (PennCERT), Philadelphia, PA March 2013 Tuberculous Meningitis: The Impact of Initial Drug Resistance on Clinical Outcomes. NYC Department of Health and Mental Hygiene, Office of Surveillance and Epidemiology, Bureau of Tuberculosis Control, NYC, NY March 2013 HIV Treatment Update 2013. HIV Planning Council, Philadelphia, PA May 2013 Tuberculous Meningitis and the BCG Vaccine. North America Vaccine Development Grand Rounds, GlaxoSmithKline, King of Prussia, PA June 2013 Novel diagnostic assays for poor anti-tuberculosis drug bioavailability. Clinical Research Conference, Division of Clinical Pharmacology, Thomas Jefferson University, Philadelphia, PA July 2013 HIV/AIDS Associated Opportunistic Infections. Case Management Annual Medical Update, Philadelphia, PA. October 2013 IGRAs in the Immunocompromised Patient: Are We Reaching the Tipping Point? Satellite Symposium, IDWeek, San Francisco, CA. November 2013 IGRAs in the HIV+ Patient: Are We Reaching the Tipping Point? Association of Nurses in AIDS Care, Atlanta, GA. Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] June 2015 June 2016 Does Immune Activation Explain Variability in Isoniazid Metabolism in HIVAssociated Tuberculosis? Division of Infectious Diseases Grand Rounds, University of Pennsylvania, Philadelphia, PA. Individualized Tuberculosis Therapies and Sutton’s Law. Division of Pulmonary Medicine Grand Rounds, New York, NY Abstracts and Presentations: 1. Vinnard C, Longworth S, Lee I, Blumberg E. Risk Factors for Nontuberculous Mycobacterial Infections in Heart and Lung Transplant Recipients. Poster presentation, 26th International Conference on Pharmacoepidemiology, Brighton, U.K., 2010. 2. Vinnard C, Winston C, Wileyto E, Macgregor R, Bisson G. Factors associated with isoniazid resistant tuberculous meningitis in the United States, 1993-2005. Late-breaking poster presentation, 50th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 2010. 3. Vinnard C, Winston C, Wileyto E, Macgregor R, Bisson G. Tuberculous meningitis in the United States 1993-2005: The association of initial isoniazid resistance with mortality. Oral presentation, 48th Annual Meeting of the Infectious Disease Society of America, Washington, D.C., 2010. 4. Longworth S, Vinnard C, Lee I, Blumberg E. Risk factors for nontuberculous mycobacterial infections in heart and lung transplant recipients. Poster presentation, 48th Annual Meeting of the Infectious Disease Society of America, Washington, D.C., 2010. 5. Vinnard C, Lee I, Linkin D. Norovirus outbreak among attendees of a hospital teaching conference. Poster presentation, Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Dallas, TX, 2011. 6. Vinnard C, Winston C, Wileyto E, Macgregor R, Bisson G. Multidrug resistant tuberculous meningitis in the United States, 1993-2005. Oral presentation, 19th World Congress of Epidemiology, Edinburgh, U.K., 2011. 7. Vinnard C, Linkin DR, Behrman A. Approach to Latent Tuberculosis among Occupational Health Providers. Poster presentation, 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2012. 8. Yates F, Linkin DR, Vinnard C. BCG Vaccination and LTBI Treatment Attitudes among Resident Physicians. Poster presentation, 51st Annual Meeting of the Infectious Disease Society of America, 2013. 9. Adams JW, Allen SW, Vinnard C. Adherence to national guidelines for latent tuberculosis infection screening among HIV-infected patients in Philadelphia. Poster presentation, International Epidemiological Association’s World Congress on Epidemiology. Anchorage, AK, 2014. 10. Janakiraman A, Yates F, Headly A, Linkin DR, Vinnard C. Do Resident Physicians Agree with LTBI Treatment Guidelines? Poster presentation, 52nd Annual Meeting of the Infectious Disease Society of America, Philadelphia, PA, 2014. 11. Chaudhari S, Vinnard C. Racial Disparities among Tuberculosis Deaths in the United States, 1999-2009. Poster Presentation, 52nd Annual Meeting of the Infectious Disease Society of America, Philadelphia, PA, 2014. 12. Zentner I, Khensouvann L, Kutzler M, Schlecht H, Bisson GP, Peloquin C, Vinnard C. A Urine Colorimetric Assay to Detect Low Peak Serum Concentrations of Pyrazinamide: A Proof-ofConcept Study. Poster presentation, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., 2014. Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] 13. Khensouvann L, Meng Z, Baliban S, Kutzler M, Bentz J, Vinnard C. Effect of P-Glycoprotein Inhibition on Rifampicin Transport Across the Caco-2 Cell Monolayer. Poster presentation, 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., 2014. 14. Khensouvann L, Kutzler M, Gumbo T, Pasipanodya J, Schlecht HP, Bisson GP, Peloquin C, Vinnard C. Urine Colorimetry to Detect Low Rifampicin Bioavailability: A Proof-of-Concept Study. Poster presentation, 45th Union World Conference on Lung Health, Barcelona, Spain, 2014. 15. Vinnard C, Proops D, Crossa A, Iwata K, Pasipanodya J, Trieu L, Munsiff S, Ahuja S. The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City. Poster presentation, ASM Microbe, Boston, MA, 2016. 16. Andrews A, Adams J, Varhese S, Vinnard C. Factors Associated with Successful Screening for Latent Tuberculosis Infection with the Interferon Gamma Release Assay in an Urban HIV Clinic. Poster presentation, ASM Microbe, Boston, MA, 2016. 17. Vinnard C, Manley I, Scott B, Bernui M, Varghese S, Adams J, Kutzler M. A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients. Poster presentation, ASM Microbe, Boston, MA, 2016. 18. Zentner I, Schlecht HP, Khensouvann L, Tamuhla N, Kutzler M, Ivaturi V, pasipanodya J, Gumbo T, Peloquin CA, Bisson GP, Vinnard C. Urine Colorimetry to Detect Low Rifampin Exposure During Tuberculosis Therapy: A Proof-of-Concept Study. Poster presentation, ASM Microbe, Boston, MA, 2016. 19. Vinnard C, Ravimohan S, Tamuhla N, Ivaturi V, Pasipanodya J, Kant S, Weissman D, Bisson GP. Immune Activation and Isoniazid Metabolism in HIV-Associated Tuberculosis. Poster presentation, ASM Microbe, Boston, MA, 2016. Publications: 1. Vinnard C, Blumberg E. 2008. Prevention of opportunistic infections in the solid organ transplant recipient. Infections in Medicine 25(9): 403-415. 2. Kranick SM, Vinnard C, Kolson DL. 2009. Propionibacterium acnes brain abscess appearing ten years after neurosurgery. Archives of Neurology 66(6): 793-5. PMID: 19506144. 3. Vinnard C, Barton T, Jerud E, Blumberg E. 2009. A report of HHV-6 associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transplantation. 15(10): 1242-6. PMID: 19790143. 4. Vinnard C, Macgregor R. 2009. Tuberculous meningitis in the HIV-infected individual. Current HIV/AIDS Reports. 6(3): 139-45. PMID: 19589299. 5. Vinnard C, Blumberg E. 2009. Detection of human herpesvirus (HHV)-6 and HHV-7 in transplant recipients: minding the gap. Transplant Infectious Disease. 11(6): 477-9. PMID: 19891754. 6. Vinnard C, Winston C, Wileyto E, Macgregor R, Bisson G. 2010. Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study. British Medical Journal. 341: c4451. PMID: 20819874. 7. Vinnard C, Winston C, Wileyto E, Macgregor R, Bisson G. 2011. Isoniazid resistant tuberculous meningitis, United States, 1993-2005. Emerging Infectious Diseases. 17(3): 539-42. PMID: 21392454. 8. Vinnard C, Winston C, Wileyto E, Macgregor R, Bisson G. 2011. Multidrug resistant tuberculous meningitis in the United States, 1993-2005. Journal of Infection. 63(3):240-2. PMID: 21784099. Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] 9. Vinnard C, Lee I, Linkin DR. Successful control of a norovirus outbreak among attendees of a hospital teaching conference. 2011. American Journal of Infection Control. 40(1):73-4. PMID: 21816511. 10. Vinnard C, Linkin DR, Localio AR, Leonard CE, Teal VL, Fishman NO, Hennessy S. 2012. Effectiveness of Interventions in Reducing Antibiotic Use for Upper Respiratory Infections in Ambulatory Care Practices. Population Health Management. In press. PMID 23113630. 11. Vinnard C, Linkin DR, Behrman A. 2012. Current Approach to Latent Tuberculosis Diagnosis and Treatment Among Medical Center Occupational Health Physicians. Infection Control and Hospital Epidemiology. 33(12):126205. PMID 23143368. 12. Vinnard C, Gopal A, Linkin DR, Maslow J. 2013. Isoniazid toxicity among an older veteran population: a retrospective cohort study. Tuberculosis Research and Treatment. 2013;2013:549473. PMID 23365735. 13. Bamford L, Ellenberg JH, Hines J, Vinnard C, Jasani A, Gross R. 2013. Factors associated with a willingness to accept rapid HIV testing in an urban emergency department. AIDS Behavior. 18(2):250-3. PMID 23536139. 14. Vinnard C, Wileyto EP, Bisson G, Winston C. 2013. First use of multiple imputation with the National Tuberculosis Surveillance System. Epidemiology Research International. doi:pii:875234. PMID 23658856. 15. Longworth S, Vinnard C, Sims K, Lee I, Barton T, Blumberg EA. 2014. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transplant Infectious Diseases. 16(1):76-83. PMID 24350627. 16. Cheema S, Vinnard C, Linkin DR. 2013. A Time-Off Incentive Was Not Associated with Influenza Vaccination Acceptance Among Healthcare Workers. Influenza Research and Treatment. Doi:10.1155/2013/209491. PMID 23878733. 17. Vetter ML, Wadden TA, Vinnard C, Moore RH, Khan Z, Volger S, Sarwer DB, Faulconbridge LF; POWER-UP Research Group. 2013. Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. International Journal of Obesity (London). 37Suppl1:S3843. PMID 23921781. 18. Yates F, Janakiraman A, Headly A, Linkin DR, Vinnard C. 2014. Attitudes towards latent tuberculosis among physicians in training: the role of BCG vaccination. Journal of Community Health. PMID 25236656. 19. Caroff DA, Norris AH, Keller S, Vinnard C, Zeitler KE, Lukaszewicz J, Zborowski KA, Linkin DR. 2014. Catheter-salvage in home infusion patients with central line-associated bloodstream infection. American Journal of Infection Control. 4(12):1331-3. PMID 25465266. 20. Longworth SA, Blumber EA, Barton TD, Vinnard C. 2015. Nontuberculous mycobacterial infections after solid organ transplantation: a survival analysis. Clinical Microbiology and Infection. 21(1):43-7. PMID 25636926. 21. Zivich S, Cauterucci M, Allen S, Vetter M, Vinnard C. 2015. Long-term virologic outcomes following bariatric surgery in patients with HIV. Obesity Research and Clinical Practice. 9(6): 633-5. PMID 26411387. 22. Arif N, Yousfi S, Vinnard C. 2016. Deaths from Necrotizing Fasciitis in the United States, 20032013. Epidemiology and Infection. 144(6): 1338-44. PMID 26548496. 23. Zentner I, Schlecht HP, Khensouvann L, Tamuhla N, Kutzler M, Ivaturi V, Pasipanodya J, Gumbo T, Peloquin CA, Bisson GP, Vinnard C. 2016. Urine Colorimetry to Detect Low Rifampin Exposure During Tuberculosis Therapy: A Proof-of-Concept Study. BMC Infectious Diseases. doi: 10.1186/s12879-016-1576-1. PMID: 27250739. Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] 24. Vinnard C, Longworth S, Mezochow A, Patrawalla A, Kreiswirth BN, Hamilton K. Deaths Related to Nontuberculous Mycobacterial Infections in the United States, 1999-2014. Annals of the American Thoracic Society. In press. Letters to the Editor: 1. Vetter M, Vinnard C, Wadden T. 2009. Perioperative safety and bariatric surgery. New England Journal of Medicine. 361(19): 1910. PMID: 19890138. 2. Vinnard C. Racial differences in rates of severe sepsis. Journal of the American Medical Association. 304(14):1556. PMID: 20940380. Book Chapters: 1. Vinnard C, Blumberg E. Endocrine and Metabolic Aspects of Tuberculosis. In: Tuberculosis and Nontuberculous Mycobacterial Infections, Sixth Edition. Schlossberg D. ASM Press, Washington, DC. 2011. Research Support: Active (direct costs): 1K23AI102639-02 (Vinnard) 9.0 Calendar NIH-NIAID $112,000 Rifampin Malabsorption in HIV+ Patients: Mechanisms and Recovery after HAART This 5-year mentored career development award will provide the PI with pharmacometrics training in the area of HIV/TB co-infection, and will test the hypotheses that markers of gut damage among HIV/TB patients will be associated with rifampicin malabsorption, and that partial recovery of rifampicin absorption will occur following the initiation of HAART. Role: PI Completed: 1R21AI104441-01 (Bisson) 0.5 Calendar NIH-NIAID $246,256 Immune Activation and Isoniazid Metabolism in HIV/TB This project will test the hypothesis that increased immune activation in HIV is associated with decreased INH clearance in patients with HIV and pulmonary tuberculosis. Role: Co-I Intramural (Vinnard) 0.5 Calendar Clinical and Translational Research Institute , Drexel University $75,000 A Novel Method to Detect Rifamycins in Biologic Samples In this project we will develop a novel approach to tag rifamycin compounds with a fluorescent dye, with the long-term goal of developing an alternate method for therapeutic drug monitoring in resource-limited settings. Role: PI Janssen (Vinnard) 0.5 Calendar Investigator Initiated Award $77,615 This project will provide pilot data towards testing the hypothesis that markers of gut inflammation Christopher Vinnard 31 Eglantine Ave Pennington, NJ 08534 (215) 983-0471 [email protected] and damage are associated with rifampicin malabsorption among HIV-infected patients. Role: PI Gates (Vinnard) 05/01/2012 - 12/31/2013 0.0 Calendar Bill & Melinda Gates Foundation $100,000 A Novel Diagnostic Test for Poor Anti-TB Drug Bioavailability The overall goal of this project is to explore urine colorimetry as an alternate diagnostic approach for the detection of low anti-tuberculosis drug bioavailability. Role: PI Intramural (Vinnard) 6/1/2012 – 12/31/2012 0.0 Calendar Clinical and Translational Pilot Research Grant Competition $25,000 Rifampicin Transport Across an In Vitro Model of the Intestinal Barrier This award supports a program to identify specific rifampicin uptake transporters in Caco-2 cells as an in-vitro model for the intestinal barrier. Role: PI 5T32AI055435-07 (Strom) 7/1/2009 – 6/30/2011 NIH-NIAID Infectious Disease Epidemiology The major goal of this grant is to train clinicians to be rigorous and independent academic investigators able to use the range of approaches available in epidemiology to address research issues.